Eczema Trial, Recruiting (NCT06998446)

Eczema Trial, Recruiting NCT06998446 Sponsor: University of California, San Francisco Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT06998446 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 50 years old or older
You are willing and able to have an MRI scan without contrast dye (for example, you do not have a pacemaker, certain types of brain surgery clips, or are not pregnant)

Who may not be able to join:

You have a history of an autoimmune disease
You have had a heart-related medical event in the last six months
Your liver or kidneys are not working well enough (specifically, a kidney filtering score below a certain level — confirm with trial site)
You currently take certain medicines that affect how your body handles salt, such as some water pills or diabetes medications, or you are currently receiving chemotherapy or antibiotic treatment
You are currently receiving light therapy or taking certain prescription medicines for a skin condition called atopic dermatitis, such as cyclosporine, methotrexate, or similar drugs that reduce immune system activity
Note: If you take a medication called dupilumab for atopic dermatitis, you may still be eligible as long as you have been taking it for at least two months and your condition is still considered severe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katrina Abuabara, M.D., University of California, San Francisco

Phone: 415-502-0433

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06998446

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: 415-502-0433

More information: https://clinicaltrials.gov/study/NCT06998446

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 50 years old or older
You are willing and able to have an MRI scan without contrast dye (for example, you do not have a pacemaker, certain types of brain surgery clips, or are not pregnant)

Who may not be able to join:

You have a history of an autoimmune disease
You have had a heart-related medical event in the last six months
Your liver or kidneys are not working well enough (specifically, a kidney filtering score below a certain level — confirm with trial site)
You currently take certain medicines that affect how your body handles salt, such as some water pills or diabetes medications, or you are currently receiving chemotherapy or antibiotic treatment
You are currently receiving light therapy or taking certain prescription medicines for a skin condition called atopic dermatitis, such as cyclosporine, methotrexate, or similar drugs that reduce immune system activity
Note: If you take a medication called dupilumab for atopic dermatitis, you may still be eligible as long as you have been taking it for at least two months and your condition is still considered severe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

12 May 2025

Est. completion

30 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Skin sodium concentration; Atopc dermatitis serverity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov